Enrique Zudaire - Researcher Profile

Publications

2 shown

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja , Deepu Madduri , Saad Z. Usmani +33 more

CARTITUDE-1 aimed to assess the safety and clinical activity of ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor T-cell therapy with two B-cell maturation anti...

2021 The Lancet 1466 citations

COX-2 Inhibition Potentiates Antiangiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models

Lihong Xu , Janine Stevens , Mary Beth Hilton +11 more

Inhibition of cyclooxygenase-2 (COX-2) inhibits angiogenesis, suppresses tumor growth, and augments the effects of traditional angiogenesis inhibitors.

2014 Science Translational Medicine 213 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,679
Institution: Janssen (United States)

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.